Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial

Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial

BackgroundThe appropriate age range for breast cancer screening remains a matter of debate. We aimed to estimate the effect of mammographic screening at ages 40–48 years on breast cancer mortality.MethodsWe did a randomised, controlled trial involving 23 breast screening units across Great Britain....

Spremljeno u:

Bibliografski detalji
Glavni autori:	Stephen W. Duffy, Daniel Vulkan, Howard Cuckle, Dharmishta Parmar, Shama Sheikh, Robert A. Smith, Andrew Evans, Oleg Blyuss, Louise Johns, Ian O. Ellis, Jonathan P. Myles, Peter Sasieni, Sue Moss
Format:	Artigo
Jezik:	engleski
Izdano:	2020
Online pristup:	https://doi.org/10.1016/s1470-2045(20)30398-3 http://www.thelancet.com/article/S1470204520303983/pdf
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti

Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial
od: Duffy, Stephen W, i dr.
Izdano: (2020)

Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
od: Duffy, Stephen, i dr.
Izdano: (2020)

Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT
od: Stephen W. Duffy, i dr.
Izdano: (2020)

False-positive results in the randomised controlled trial of mammographic screening from age 40 (‘Age’ trial)
od: Johns, Louise E, i dr.
Izdano: (2010)

Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial
od: Sue Moss, i dr.
Izdano: (2015)

Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures
od: Moss, S, i dr.
Izdano: (2005)

Targeted encouragement of GP consultations for possible cancer symptoms: a randomised controlled trial
od: Laake, Jean-Pierre, i dr.
Izdano: (2020)

Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years
od: Moss, S, i dr.
Izdano: (2005)

Interim results from the Age Trial
od: Moss, S, i dr.
Izdano: (2004)

Malmö mammographic screening trial.
od: Tabár, L., i dr.
Izdano: (1989)

An ongoing case-control study to evaluate the NHS breast screening programme
od: Massat, Nathalie J, i dr.
Izdano: (2013)

An ongoing case–control study to evaluate the NHS Bowel Cancer Screening Programme
od: Massat, Nathalie J, i dr.
Izdano: (2014)

Trial of mammography in women under 50 is ethical
od: Moss, Sue, i dr.
Izdano: (1998)

Final Results of the Prospective FH02 Mammographic Surveillance Study of Women Aged 35–39 at Increased Familial Risk of Breast Cancer()
od: Evans, D.G., i dr.
Izdano: (2019)

Should women 40 to 49 years of age be offered mammographic screening?
Izdano: (2006)

Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time
od: Duffy, Stephen W, i dr.
Izdano: (2013)

Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time
od: Stephen W. Duffy, i dr.
Izdano: (2013)

Updated results of the Gothenburg Trial of Mammographic Screening
od: Bjurstam, Nils G., i dr.
Izdano: (2016)

Prospective estimation of rates of change in mammographic parenchymal patterns: influence of age and of hormone replacement (HRT) therapy
od: Myles, JP, i dr.
Izdano: (2004)

Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based study
od: Castanon, Alejandra, i dr.
Izdano: (2020)

Rebuttal: Should women 40 to 49 years of age be offered mammographic screening?
Izdano: (2006)

Assessing the amount of unscheduled screening (‘contamination’) in the control arm of the UK ‘Age’ Trial
od: Kingston, Nicola, i dr.
Izdano: (2010)

A case-control study to evaluate the impact of the breast screening programme on mortality in England
od: Maroni, Roberta, i dr.
Izdano: (2020)

Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
od: Duffy, S W, i dr.
Izdano: (2013)

The association of age at menarche and adult height with mammographic density in the International Consortium of Mammographic Density
od: Ward, Sarah V., i dr.
Izdano: (2022)

Overdiagnosis and overtreatment of breast cancer: Estimates of overdiagnosis from two trials of mammographic screening for breast cancer
od: Duffy, Stephen W, i dr.
Izdano: (2005)

Estimation of currently attainable benefit from mammographic screening of women aged 40-49 years
od: Stephen A. Feig
Izdano: (1995)

Overdiagnosis and overtreatment of breast cancer: Estimates of overdiagnosis from two trials of mammographic screening for breast cancer
od: Stephen W. Duffy, i dr.
Izdano: (2005)

Variation in Mammographic Breast Density by Time in Menstrual Cycle Among Women Aged 40-49 Years
od: Emily White, i dr.
Izdano: (1998)

Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.
od: Andersson, I., i dr.
Izdano: (1988)

Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial.
od: Ingvar Andersson, i dr.
Izdano: (1988)

Mammographic Breast Density and Urbanization: Interactions with BMI, Environmental, Lifestyle, and Other Patient Factors
od: Perry, Nick, i dr.
Izdano: (2020)

Malmö mammographic screening trial: Authors' reply
od: Andersson, Ingvar, i dr.
Izdano: (1989)

The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit.
od: Tabar, L, i dr.
Izdano: (1989)

The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit.
od: Làszló Tabár, i dr.
Izdano: (1989)

Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis
od: Rebolj, Matejka, i dr.
Izdano: (2018)

Pathology results from the UK Age Trial
od: Ellis, IO, i dr.
Izdano: (2004)

Neuroblastoma Screening at 1 Year of Age: The Final Results of a Controlled Trial
od: Berthold, Frank, i dr.
Izdano: (2021)

Opportunistic offering of self-sampling to non-attenders within the English cervical screening programme: a pragmatic, multicentre, implementation feasibility trial with randomly allocated cluster intervention start dates (YouScreen)
od: Anita WW Lim, i dr.
Izdano: (2024)

Faecal immunochemical testing in bowel cancer screening: Estimating outcomes for different diagnostic policies
od: Li, Shuping J, i dr.
Izdano: (2020)